OurCrowd Portfolio Company SaNOtize’s COVID Treatment Reduces Viral Load by 95% in 24 Hours
OurCrowd portfolio company SaNOtize says that a UK clinical trial has delivered solid results as COVID-19 treatment. A self-administered nasal spray is said to reduce the viral load by more than 95% in 24 hours and by 99% in 72 hours. Trial results indicated that… Read More
Read more in: Global, General News, Offerings | Tagged chris miller, coronavirus, covid-19, ourcrowd, sanotize, uk, united kingdom